Saturday, December 20, 2014

Study: Kadcyla Not Superior to Herceptin and Chemotherapy for PFS in HER2-Positive Breast Cancer

… with previously untreated, advanced HER2-positive breast cancer live significantly longer without the …
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)